美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HAE 美国血液技术

休市中 05-02 16:00:00 EDT

63.85

+0.86

+1.37%

盘后63.85

+0.000.00%

16:20 EDT

最高64.42	最低63.33	成交量53.48万
今开63.77	昨收62.99	日振幅1.73%
总市值32.08亿	流通市值31.77亿	总股本5,024万
成交额3,419万	换手率1.07%	流通股本4,975万
市净率3.54	ROE14.06%	每股收益2.54
52周最高97.97	52周最低55.30	市盈率25.15
股息0.00	股息收益率0.00	ROA6.33%

北京优虎网络科技有限公司

{"stockData":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"美国血液技术","latestPrice":63.85,"timestamp":1746216000000,"preClose":62.99,"halted":0,"volume":534756,"hourTrading":{"tag":"盘后","latestPrice":63.85,"preClose":63.85,"latestTime":"16:20 EDT","volume":13886,"amount":886620.12,"timestamp":1746217200452},"delay":0,"floatShares":49750885,"shares":50237466,"eps":2.538856,"marketStatus":"休市中","change":0.86,"latestTime":"05-02 16:00:00 EDT","open":63.77,"high":64.42,"low":63.33,"amount":34191659.60658,"amplitude":0.017304,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.538856,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":673761600000,"exchange":"NYSE","adjPreClose":62.99,"preHourTrading":{"tag":"盘前","latestPrice":64.99,"preClose":62.99,"latestTime":"05:55 EDT","volume":26,"amount":1672.7399,"timestamp":1746179700810},"postHourTrading":{"tag":"盘后","latestPrice":63.85,"preClose":63.85,"latestTime":"16:20 EDT","volume":13886,"amount":886620.12,"timestamp":1746217200452},"volumeRatio":1.175418112144693,"impliedVol":0.6341,"impliedVolPercentile":0.852},"requestUrl":"/m/hq/s/HAE/tweets","defaultTab":"tweets","newsList":[{"id":"2514086737","title":"美国血液技术盘中异动 下午盘急速上涨5.00%报66.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514086737?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:53","pubTimestamp":1740426800,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时53分，美国血液技术股票出现异动，股价快速拉升5.00%。截至发稿，该股报66.17美元/股，成交量38.3166万股，换手率0.76%，振幅5.12%。美国血液技术股票所在的医疗设备行业中，整体涨幅为0.25%。其相关个股中，Anbio Biotechnology、奥瑞许科技、美国血液技术涨幅较大，Sharps Technology Inc.、Glucotrack, Inc.、Microbot Medical Inc.较为活跃，换手率分别为44.95%、6.01%、5.07%，振幅较大的相关个股有Sharps Technology Inc.、Nexgel Inc C/Wts 27/12/2026 、Precision Optics Corporation, Inc.，振幅分别为23.85%、15.98%、14.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035320a25257e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035320a25257e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B64QTZ34.USD","LU0106261612.USD","IE00BLDYK493.USD","BK4198","LU0012050646.USD","LU0205193047.USD","LU0205194284.USD","HAE","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"1155255330","title":"异动解读 | 美国血液技术公司股价盘中大跌5.25% 分析师下调评级预期所致","url":"https://stock-news.laohu8.com/highlight/detail?id=1155255330","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155255330?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:26","pubTimestamp":1738956391,"startTime":"0","endTime":"0","summary":"美国血液技术公司今日盘中股价大跌5.25%,引发了市场的广泛关注。根据相关新闻报道,导致该公司股价下跌的主要原因是分析师对其未来前景的预期下调。知名投资银行摩根大通证券公司今日维持了对美国血液技术的\"优于大市\"评级,但将公司的目标股价从125美元下调至100美元。美国血液技术公司主要从事血液和血浆成分采集、加工和输送,业务分为血浆、血液中心和医院三个分部。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 美国血液技术公司股价盘中大跌5.25% 分析师下调评级预期所致","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"2509778144","title":"美国血液技术盘中异动 下午盘大幅跳水5.06%报59.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509778144?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:15","pubTimestamp":1738955721,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时15分，美国血液技术股票出现波动，股价快速下跌5.06%。截至发稿，该股报59.80美元/股，成交量146.523万股，换手率2.92%，振幅6.33%。美国血液技术股票所在的医疗设备行业中，整体跌幅为0.68%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208031521a23d5d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208031521a23d5d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0106261612.USD","IE00BLDYK493.USD","LU1169590202.USD","BK4198","IE00B64QTZ34.USD","HAE","LU0205194284.USD","LU1169589451.USD","LU0012050646.USD","LU0205193047.USD"],"gpt_icon":0},{"id":"2509729791","title":"摩根大通证券公司：维持Haemonetics(HAE.US)评级，由优于大市调整至优于大市评级, 目标价由125.00美元调整至100.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509729791","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509729791?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:02","pubTimestamp":1738947740,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Haemonetics(HAE.US)评级，由优于大市调整至优于大市评级, 目标价由125.00美元调整至100.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08010248031451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HAE","399975","159848"],"gpt_icon":0},{"id":"2509572976","title":"雷蒙德詹姆斯公司：重申Haemonetics(HAE.US)评级，由强烈买入调整至强烈买入评级, 目标价由120.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509572976","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509572976?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:02","pubTimestamp":1738947740,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司：重申Haemonetics(HAE.US)评级，由强烈买入调整至强烈买入评级, 目标价由120.00美元调整至115.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08010248031449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HAE"],"gpt_icon":0},{"id":"1111478372","title":"异动解读 | 美国血液技术因下调业绩预期 盘中一度大跌近11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111478372","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111478372?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:42","pubTimestamp":1738856552,"startTime":"0","endTime":"0","summary":"美国医疗设备制造商美国血液技术(HAE)2月6日盘中一度大跌10.74%,引发市场关注。\n\n公司当天公布下调了2025财年的预期销售增长率,从此前的5%-8%下调至3%-5%,这是导致该股大跌的主因。同时,公司第三季度的营收3.49亿美元也低于分析师预期的3.53亿美元。\n\n美国血液技术主营业务包括血液和血浆成分采集、外科手术室和医院输血服务等。公司去年第三季度每股利润1.19美元高于市场预期,但由于业绩预期的下调,导致投资者对其长期增长前景持谨慎态度。该股过去12个月股价已下跌约17%。机构评级显示,82%的分析师给予买入评级,主要看好其血浆和医院业务增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"2509774312","title":"美国血液技术盘中异动 急速下跌8.80%报64.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509774312?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852370,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，美国血液技术股票出现波动，股价快速下挫8.80%。截至发稿，该股报64.97美元/股，成交量2.4341万股，换手率0.05%，振幅1.01%。美国血液技术股票所在的医疗设备行业中，整体跌幅为0.19%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223250a23bce9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223250a23bce9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169590202.USD","IE00B64QTZ34.USD","LU0205193047.USD","HAE","LU1169589451.USD","BK4198","LU0012050646.USD","IE00BLDYK493.USD","LU0106261612.USD","LU0205194284.USD"],"gpt_icon":0},{"id":"1104450572","title":"Haemonetics 2025年第三季度调整后每股收益$1.19超出预期$1.17，销售额$3.49亿低于预期$3.5293亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1104450572","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104450572?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:26","pubTimestamp":1738841182,"startTime":"0","endTime":"0","summary":"Haemonetics报告季度每股收益为$1.19，高于分析师预期的$1.17，比预期高出1.71%。这是比去年同期每股收益$1.04增加了14.42%。公司报告季度销售额为$3.49亿，低于分析师预期的$3.5293亿，低1.11%。以上内容来自Benzinga Earnings专栏，原文如下：Haemonetics  reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.17 by 1.71 percent. This is a 14.42 percent increase over earnings of $1.04 per share from the same period last year.  The company reported quarterly sales of $349.00 million which missed the analyst consensus estimate of $352.93 million by 1.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Haemonetics 2025年第三季度调整后每股收益$1.19超出预期$1.17，销售额$3.49亿低于预期$3.5293亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE"],"gpt_icon":0},{"id":"2509499545","title":"美国血液技术盘中异动 临近收盘急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509499545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509499545?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:39","pubTimestamp":1738701572,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时39分，美国血液技术股票出现波动，股价大幅上涨5.08%。截至发稿，该股报69.51美元/股，成交量64.9685万股，换手率1.29%，振幅5.19%。美国血液技术股票所在的医疗设备行业中，整体涨幅为0.06%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205043932abc26b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205043932abc26b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","LU0106261612.USD","BK4198","LU0205194284.USD","LU1169590202.USD","IE00B64QTZ34.USD","IE00BLDYK493.USD","LU0012050646.USD","HAE","LU0205193047.USD"],"gpt_icon":0},{"id":"2503916280","title":"美国血液技术盘中异动 早盘急速下跌5.00%报71.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503916280?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:52","pubTimestamp":1737039121,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时52分，美国血液技术股票出现异动，股价大幅下跌5.00%。截至发稿，该股报71.30美元/股，成交量7.6882万股，换手率0.15%，振幅4.88%。美国血液技术股票所在的医疗设备行业中，整体跌幅为0.29%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225201abad54a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225201abad54a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B64QTZ34.USD","LU0106261612.USD","IE00BLDYK493.USD","BK4198","LU0012050646.USD","LU0205193047.USD","LU0205194284.USD","HAE","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2503467660","title":"美国血液技术盘中异动 快速下跌5.20%报75.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503467660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503467660?lang=zh_cn&edition=full","pubTime":"2025-01-16 02:57","pubTimestamp":1736967463,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日02时57分，美国血液技术股票出现异动，股价快速下跌5.20%。截至发稿，该股报75.81美元/股，成交量21.8465万股，换手率0.43%，振幅7.82%。美国血液技术股票所在的医疗设备行业中，整体涨幅为4.11%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011602574398677495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011602574398677495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLDYK493.USD","LU0205194284.USD","LU1169590202.USD","LU0205193047.USD","IE00B64QTZ34.USD","BK4198","LU1169589451.USD","HAE","LU0106261612.USD","LU0012050646.USD"],"gpt_icon":0},{"id":"2484510190","title":"美国血液技术2024财年第三财季实现净利润33.83百万美元，同比增加35.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484510190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484510190?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:00","pubTimestamp":1731772808,"startTime":"0","endTime":"0","summary":"11月17日，美国血液技术公布财报，公告显示公司2024财年第三财季净利润为33.83百万美元，同比增加35.81%；其中营业收入为3.46亿美元，同比增加8.81%，每股基本收益为0.66美元。从资产负债表来看，美国血液技术总负债16.46亿美元，其中短期债务5.43百万美元，资产负债比为1.54，流动比率为3.49。机构评级：截至2024年11月17日，当前有10家机构对美国血液技术目标价做出预测，其中目标均价为110.80美元，其中最低目标价为85.00美元，最高目标价为125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000019abc78df6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000019abc78df6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE"],"gpt_icon":0},{"id":"1124602679","title":"异动解读 | 美国血液技术财报超预期  股价大涨近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124602679","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124602679?lang=zh_cn&edition=full","pubTime":"2024-11-08 11:08","pubTimestamp":1731035333,"startTime":"0","endTime":"0","summary":"周二,医疗器械制造商美国血液技术公司(HAE)公布了2024财年第三季度财报,超出市场预期,公司股价当日大涨7.47%,引发市场关注。\n\n财报显示,美国血液技术第三季度调整后每股收益为1.12美元,高于分析师平均预期的1.07美元。该公司本季度营收同比增长8.6%,达到3.4551亿美元,虽略低于预期的3.4265亿美元,但整体表现依然出色。\n\n分析师对美国血液技术的长期前景持乐观态度。目前分析师平均给予该公司\"买入\"评级,预计其未来12个月股价目标中位数为113.5美元。分析人士认为,作为医疗设备和用品行业的龙头企业,该公司在技术、研发和渠道优势等多方面具备良好发展潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"1141327239","title":"异动解读 | 美国血液技术(HAE)公布强劲财报 股价大涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141327239","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141327239?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:37","pubTimestamp":1730990222,"startTime":"0","endTime":"0","summary":"美国血液技术公司公布了截至2024年9月30日的2024财年第三季度财报,业绩超出分析师预期,股价当日大涨7.47%,引发市场热议。财报显示,美国血液技术当季度调整后每股收益为1.12美元,超过分析师平均预期的1.07美元。分析师对美国血液技术的长期前景持乐观态度。目前分析师平均对该公司股票的评级为\"买入\",预计其未来12个月股价目标中位数为113.5美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"2481189956","title":"美国血液技术盘中异动 早盘股价大涨8.75%报85.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481189956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481189956?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:34","pubTimestamp":1730990066,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时34分，美国血液技术股票出现异动，股价快速拉升8.75%。截至发稿，该股报85.00美元/股，成交量7987股，换手率0.02%，振幅1.36%。美国血液技术股票所在的医疗设备行业中，整体涨幅为0.14%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722342695bde6e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722342695bde6e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLDYK493.USD","BK4198","LU0106261612.USD","LU0205193047.USD","LU1169590202.USD","LU0012050646.USD","LU1169589451.USD","HAE","IE00B64QTZ34.USD","LU0205194284.USD"],"gpt_icon":0},{"id":"1117245921","title":"异动解读 | 美国血液技术财报超预期 盘前股价大涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117245921","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117245921?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:31","pubTimestamp":1730989880,"startTime":"0","endTime":"0","summary":"美国血液技术(HAE)公司周二盘前股价大涨6.19%,投资者对其最新财报业绩表现反应热烈。\n\n美国血液技术公司公布的截至9月30日的季度调整后每股收益为1.12美元,超出分析师预期的1.07美元。该公司本季度营收同比增长8.6%至3.4551亿美元,但略低于分析师3.4265亿美元的预期区间。\n\n尽管营收略有失算,但美国血液技术依然交出了可观的业绩。分析师普遍看好该公司长期前景,给予\"买入\"的评级。分析师认为,公司在医疗设备、用品和分销领域具有良好的发展潜力,预计其未来12个月股价目标中位数为113.5美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"2470508715","title":"美国血液技术盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470508715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470508715?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:49","pubTimestamp":1727448561,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时49分，美国血液技术股票出现异动，股价急速拉升5.17%。截至发稿，该股报80.51美元/股，成交量27.8626万股，换手率0.54%，振幅4.13%。美国血液技术股票所在的医疗设备行业中，整体涨幅为0.78%。其相关个股中，Staar Surgical Company、Infusystems Holdings, Inc.、美国血液技术涨幅较大，Innovative Eyewear, Inc.、Sharps Technology Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为2.01%、1.34%、1.02%，振幅较大的相关个股有Bionano Genomics, Inc.、Glucotrack, Inc.、Singular Genomics Systems, Inc.，振幅分别为11.10%、10.82%、8.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927224921ab66863c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927224921ab66863c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B64QTZ34.USD","LU0205193047.USD","LU1169590202.USD","LU0012050646.USD","LU0106261612.USD","LU0205194284.USD","LU1169589451.USD","HAE","BK4198","IE00BLDYK493.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.haemonetics.com","stockEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":-0.003},{"period":"3month","weight":-0.0753},{"period":"6month","weight":-0.1067},{"period":"1year","weight":-0.3159},{"period":"ytd","weight":-0.1822}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Haemonetics Corporation成立于1971年，是一个全球性医疗设备公司,致力于为客户提供创新的血液管理解决方案——血浆来源收集者,采血机构和医院,在输血行业医疗设备系统方面有着强大的品牌优势,为客户提供解决方案的同时还提供信息技术平台和增值服务,其解决方案帮助患者改善临床结果，并提高血液中的供应链效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.441176,"avgChangeRate":-0.017038},{"month":2,"riseRate":0.441176,"avgChangeRate":-0.01304},{"month":3,"riseRate":0.676471,"avgChangeRate":0.021348},{"month":4,"riseRate":0.470588,"avgChangeRate":-0.02463},{"month":5,"riseRate":0.529412,"avgChangeRate":0.015849},{"month":6,"riseRate":0.588235,"avgChangeRate":0.019344},{"month":7,"riseRate":0.676471,"avgChangeRate":0.018801},{"month":8,"riseRate":0.735294,"avgChangeRate":0.029718},{"month":9,"riseRate":0.529412,"avgChangeRate":0.016681},{"month":10,"riseRate":0.5,"avgChangeRate":-0.006116},{"month":11,"riseRate":0.529412,"avgChangeRate":0.029908},{"month":12,"riseRate":0.588235,"avgChangeRate":0.02413}],"exchange":"NYSE","name":"美国血液技术","nameEN":"Haemonetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美国血液技术,HAE,美国血液技术股票,美国血液技术股票老虎,美国血液技术股票老虎国际,美国血液技术行情,美国血液技术股票行情,美国血液技术股价,美国血液技术股市,美国血液技术股票价格,美国血液技术股票交易,美国血液技术股票购买,美国血液技术股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}